baber/WOPTO huggingface dataset:
Patent CA-2645322-A1 (CA)
Title: Methods of treating lupus using cd4 antibodies
Inventor: IRVING BRYAN
IPC: C07K16/28
Filed: 2007-03-14
Abstract: Methods of treating lupus, including systemic lupus erythematosus, cutaneous lupus erythmetosus, and lupus nephritis, are provided. The methods involve administration of a combination of a non-depleting CD4 antibody and another compound used clinically or experimentally to treat lupus. Methods of treating lupus nephritis by administration of a non-depleting CD4 antibody that results in an improvement in renal function and/or a reduction in proteinuria or active urinary sediment are also provided. Methods of treating multiple sclerosis by administration of a non-depleting CD4 antibody, optionally in combination with another compound used clinically or experimentally to treat MS, are described. Methods of treating transplant recipients and subjects with rheumatoid arthritis, asthma, psoriasis, Crohn's disease, ulcerative colitis, and Sjogren's syndrome are also provided.
Patent CA-2646205-A1 (CA)
Inventor: SENS RUDIGER
IPC: C10L1/00
Filed: 2007-03-07
Abstract: Phthalocyanines of the formula (I) in which the symbols and indices have the meanings given in the description are suitable as marking substances for liquids, in particular mineral oils.
Patent CA-2646797-A1 (CA)
Inventor: KATAYAMA YUKIHISA
IPC: H01M8/10
Filed: 2007-03-27
Abstract: Compositing is carried out using an imide network polymer as a high-density electrolyte material (1) to enhance the strength and improve the durability, (2) to realize a larger area, and (3) to facilitate handling in the synthesis of a membrane, whereby a composite electrolyte membrane having a high level of ion conductivity can be formed and, further, the composite electrolyte membrane can be applied to a solid polymer electrolyte fuel cell to realize a high-performance fuel cell. The above advantages can be attained by improving the degree of filling of the imide network polymer into the porous membrane.
Patent CA-2651788-A1 (CA)
Title: System, method and corresponding apparatus for storing, retrieving and delivering unit dose blisters
Inventor: GREYSHOCK SHAWN T
IPC: A61J7/00
Filed: 2007-05-10
Abstract: A system, method and corresponding apparatus are provided for storing, retrieving and delivering unit dose blisters in their natural, raw state (i.e., without over-wrapping or repackaging). In particular, a plurality of unit dose blister mounts are configured to position a corresponding plurality of different types of unit dose blisters in a predetermined, repeatable orientation, so that they can be retrieved and delivered using, for example, an automated retrieval system. The storage apparatus (or unit dose blister mount) may include a cavity that is configured to receive a iinit dose medication or medication cavity of the unit dose blister in such a way that the unit dose blister lies substantially flat in the horizontal plane, enabling any identification information displayed on the underside of the unit dose blister (i.e., the side opposite the unit dose medication, or medication cavity) to be viewed.
Patent CA-2652003-A1 (CA)
Inventor: FELIX OLIVIER
IPC: A61L27/34
Filed: 2007-05-16
Abstract: L'invention a pour objet une méthode de construction d'un biomatériau art ificiel vivant fonctionnel, caractérisée par l'assemblage couche par couche (3D) d'une matrice et de couches 2D de cellules vivantes fonctionnelles en c ontrôlant leurs interactions et la structuration 3D en fonction de l'organis ation et de la forme finale souhaitées pour le biomatériau, où chaque couche a son propre motif adapté aux couches voisines et ô la fonctionnalité des b iomatériaux artificiels entiers. Application dans le domaine biomédical et e n nanobiotechnologie.
Patent CA-2653568-A1 (CA)
Inventor: WYSS MARTIN
IPC: A61M39/10
Filed: 2007-02-13
Abstract: The invention relates to an infusion set for introducing liquid medicaments into the body of a patient. The infusion set comprises a first structural part (1) with a cannula (2) protruding from it, and a second structural part (3) with a connection port (4) for the connector (5) of a supply line (6). The first structural part (1) and the second structural part (3) are designed in such a way, and connected to each other in such a way, that they are inseparable and are able to rotate relative to each other and, in each relative position of rotation, form a channel (7) for delivering a liquid from the connection port (4) to the cannula (2) or for withdrawing a liquid from the cannula (2) to the connection port (4). In addition, the connection port (4) is arranged on the second structural part (3) in such a way that the coupling and uncoupling of the connector (5) in each case take place in a direction transverse to the longitudinal axis of the cannula (2). By means of the invention, it is possible to make available infusion sets which offer a high level of comfort to the wearer and which at the same time are safe against operating errors.
Patent CA-2656749-A1 (CA)
Inventor: BRASSARD DANIEL P
IPC: A63G21/18
Filed: 2009-02-27
Abstract: A waterslide bowl has a fixed rider path from entrance to exit. The bowl comprises a trough which is made of a plurality of sets of trough sections, attached together, in which the trough sections of a given set are the same and nest together side-by-side, permitting the rider surface of the bowl to be made from trough sections having a small number of different shapes. This reduces the number of molds that would otherwise be required to make the trough sections. The waterslide bowl may also have two or more separate troughs, nested together, whereby the bowl may be ridden in by multiple riders at the same time, each in his or her own trough.
Patent CA-2657365-A1 (CA)
Inventor: HILBIG KLAUS
IPC: D21H17/59
Filed: 2007-06-29
Abstract: A multiply tissue is described. The article comprises a softening lotion, preferably silicon-based, and an embossment of the external surface. The embossment forms a network of discrete depressions. The embossment has particular configuration and induces a ply separation force within a defined range. The multiply tissue exhibits enhanced performance for softness, strength and ply delamination. The invention also relates to the process of making such a multiply article.
Patent CA-2658507-A1 (CA)
Title: Medical tubing set sheath
Inventor: SCHNELL WILLIAM J
IPC: A61M5/178
Filed: 2007-07-18
Abstract: A medical tubing set sheath is provided which includes a retention portion for attaching the sheath to a collar of a connector attached to the medical tubing set. The sheath may serve as a handle to facilitate torque-locking of the connector to another connector. The sheath may also include a ratcheting mechanism in order to allow for the sheath to ratchet upon application of excess torque, when the tubing set is being attached to a peripheral tubing set. The sheath may also include a needle receiving portion, so that the sheath provides for a needle protector, which may be retained in a position displaced from the needle in order to insure that the needle is exposed when removed from its packaging, and can be quickly and easily inserted in a patient's arm.
Patent CA-2663894-A1 (CA)
Inventor: WEBB JONATHAN GARRICK
IPC: E21B19/24
Filed: 2007-08-24
Abstract: A centralizing device (1) for an elongated body (16) which is located in a mousehole machine (2), the centralizing device (1) being at the upper port ion of the mousehole machine (2), and the centralizing device (1) being supp orted and rotatable around a substantially horizontal axis of rotation (22) extending through the opening (10) of the mousehole machine, and the central izing device (1) including two centralizing bows (24) located on radially op posite sides of the axis of rotation (22).
Patent CA-2665773-A1 (CA)
Inventor: KAY DENIS G
IPC: C12Q1/00
Filed: 2009-05-01
Abstract: The invention relates to compositions for use in animal models of neurodegenerative disease and methods therefor. More particularly, the invention relates to the use of neurotoxic sterol glycosides or neurotoxic glycolipids, or combinations thereof, in animal models of neurodegenerative disease. Neurotoxicity-modulating chromenols can also be used in these animal models in combination with the neurotoxic sterol glycosides or neurotoxic glycolipids, or combinations thereof. (see above formula)
Patent CA-2669953-A1 (CA)
Inventor: NUNN KAYREN JOY
IPC: B60R13/08
Filed: 2007-11-16
Abstract: A multi-layer nonwoven composite material includes base layers which impart desired properties. The number of base layers can vary as desired for desired properties in order to tune the resulting multi-layer composite material. In a preferred composite material, three base layers are provided to impart sound deadening, sound dispersion, sound absorption, and sound durability. The base layers are first produced from constituent fibers to form constituent webs. These webs are then combined into a multi-layer substrate. A barrier layer may be applied to the multi-layer substrate to impart additional properties. A face layer may be adhered to form a multi-layer nonwoven composite material. The barrier material imparts fire retardancy water resistance while the face carpet imparts cosmetic and/or tactile qualities. Other materials, such as chemical additives, can be applied to the composite material to achieve desired characteristics.
Patent CA-2670680-A1 (CA)
Inventor: CARCAGNO GABRIEL EDUARDO
IPC: F16L58/10
Filed: 2007-11-27
Abstract: Coating systems which provide corrosion resistance and, optionally, lubrication, for threaded connections are disclosed. The compositions comprise a first coating composition 200 comprising polymer matrices of polyimides or epoxies which are modified with small amounts of a fluorine containing polymer. Also present in the coating compositions are corrosion inhibiting agents and inorganic particles having a mean diameter of between approximately 10 nm and 10 µm. Solid lubricants, which may include at least one of PTFE, HDPE, Graphite, and MoS2, are optionally added to provide the first coating with a low coefficient of friction. The coating systems may further comprise a second coating composition 202, comprising a solid lubricant dispersed within an epoxy resin and a solvent. The first and second coating compositions 200, 202 are deposited on at least a portion of at least one of the pin and box members 100, 104 of the threaded connections.
Patent CA-2671947-A1 (CA)
Inventor: POITZSCH MARTIN E
IPC: E21B47/12
Filed: 2007-12-03
Abstract: A technique enables sensing one or more wellbore parameters along a specific well zone. A section of instrumented coiled tubing (36) is provided with a sensor array (40) extending along its exterior. The sensor array is designed to sense well fluid related parameters and may comprise an optical fiber sensor. A cross-over (47) allows the sensor array to communicate with a surface location via a control line routed along a coiled tubing interior.
Patent CA-2674909-A1 (CA)
Title: Ferrure articulee
Inventor: VOSS HANS WERNER
IPC: B60N2/90
Filed: 2007-05-02
Abstract: L'invention concerne une ferrure articulée pour des sièges de véhicules avec un élément de ferrure stationnaire et un élément de ferrure pivotant, lesquels sont reliés ensemble de manière à pivoter autour d'un axe de pivotement (2), le mouvement de pivotement de l'élément pivotant pouvant être bloqué en continu grâce à un dispositif de blocage. Un premier élément de blocage (4) est relié en solidarité de rotation avec l'élément de ferrure stationnaire et un second élément de blocage (5) est relié en solidarité de rotation avec l'élément de ferrure pivotant. A cet effet, les éléments de blocage situés en vis-à-vis l'un de l'autre, coaxialement à l'axe de pivotement (2), peuvent dans ce cas être accouplés ensemble en solidarité de rotation et désaccouplés à l'aide d'un dispositif d'actionnement.
Patent CA-2677292-A1 (CA)
Inventor: KOHL EDWIN
IPC: A61J7/04
Filed: 2008-01-28
Abstract: A packaged product combination comprises a number of different medicaments of different shape and/or colour, the actual shape and/or colour of the medicaments providing user information relating to the medicament, for example a recommended dosage time in relation to meal times. For example, products to be taken before meal times can be elongate, products to be taken at meal times can be circular, and products to be taken after meal times can be triangular. In this way, the invention helps patients take the medication correctly, such that patients will longer be able to self-medicate and will not be reliant on inpatient care.
Patent CA-2677702-A1 (CA)
Title: Transcoder media time conversion
Inventor: LOUKAS SERAFIM S JR
IPC: H04N7/24
Filed: 2008-02-29
Abstract: In general, this disclosure describes techniques of compensating for differences between a clock associated with an input stream of media data and a clock associated with an output stream of media data. Due to drift between a clock that governs the rate at which a transcoder receives media data units ( MDUs ) and a clock that governs the rate at which the transcoder outputs MDUs, the transcoder may receive MDUs at a rate that is faster or slower than a rate at which the transcoder outputs the MDUs. The transcoder compensates for such differences by identifying sets of received MDUs that account for a time equal to an output period minus a correction magnitude, modifying the identified sets of MDUs such that the sets of MDUs account for a time equal to the output period, and outputting the modified sets of MDUs as part of the output stream.
Patent CA-2678056-A1 (CA)
Inventor: FOGLE JAMES C
IPC: B31B50/02
Filed: 2008-02-25
Abstract: A carton (190) is constructed from a multi-ply blank (8) including an exterior blank (5) and an interior blank (6). Adhesive (T) is applied to the exterior blank (5) using an applicator (210) capable of transverse movement and/or rotation.
Patent CA-2678904-A1 (CA)
Inventor: MINTY ANDREW
IPC: B64D37/34
Filed: 2008-03-05
Abstract: A water scavenging system (1) for removing water from an aircraft fuel tank (2), the water scavenging system comprising: a water line (10); and a valve (20) which is configured to control the flow of water in the water line in response to a change in an effective angle of the valve. In use, the valve opens automatically in response to an increase in the effective pitch of the aircraft during take off and climb. The valve comprises: a pendulum (40); and a valve closure member (46) which is coupled to the pendulum such that a change in the angular position of the pendulum relative to the water line causes the valve closure member to move from a closed position in which the valve closure member impedes the flow of water in the water line to anopen position in which water can flow through the valve.
Patent CA-2679281-A1 (CA)
Inventor: BAUDER EDWARD MARSHALL
IPC: E02D29/067
Filed: 2007-09-25
Abstract: La présente invention concerne un tunnel sous-marin suspendu (6) comportant un puits (10) avec des surfaces supérieure et inférieure généralement convexes (12, 13) assemblées sur des côtés profilés transversalement s'étendant longitudinalement (14, 15). Une ou des ouvertures (20a, 20b) pour le passage de trafic s'étend longitudinalement à travers le puits (10). Le puits (10) présente une flottabilité positive nette et est amarrée à une profondeur uniforme au-dessous du niveau de la mer (5) par de attaches (32) ancrées au fond de mer (4).
Patent CA-2679831-A1 (CA)
Inventor: LU PETER S
IPC: A61K38/16
Filed: 2008-02-29
Abstract: The invention provides methods for treating stroke and compositions for use in the same. The methods employ a chimeric peptide pf an active peptide and an internalization peptide. The internalization peptide is a tat variant that promotes uptake of itself and a linked active peptide into a cell without substantial binding to N-type calcium channels. Use of the tat variant allows treating of stroke free of certain side effects associated with binding to N-type calcium channels. Tat variant peptides can also be linked to other active agent for use in treating other diseases.
Patent CA-2679932-A1 (CA)
Title: Integrated imaging and biopsy system
Inventor: DIETZ TIMOTHY G
IPC: G16H10/40
Filed: 2008-02-19
Abstract: A diagnostic station integrates patient support, imaging, biopsy, and treatment. An illustrative version of a prone mammography table localizes a breast with an imaging modality (e.g., X-ray, etc.) based upon a rotating C-arm that may encircle the localized breast. A biopsy system is integrated into the controls and displays or user interface of the diagnostic station, sharing integrated utilities (e.g., vacuum, power, data communication, etc.). Ancillary devices may be identified and authenticated by the integrated system, such as to base available functionality on the identification and/or authentication of an ancillary device. Ancillary devices that may be integrated with the system may include devices that are operable to perform surgical, therapeutic, diagnostic, or other functions.
Patent CA-2680330-A1 (CA)
Title: K-ras and b-raf mutations and anti-egfr antibody therapy
Inventor: BARDELLI ALBERTO
IPC: C12Q1/68
Filed: 2008-03-11
Abstract: The present application relates to K-ras mutations, to polynucleotides encoding mutant K-ras polypeptides, and to methods of identifying K-ras mutations. The present application also relates to B-raf mutations, to polynucleotides encoding mutant B-raf polypeptides, to vectors containing those polynucleotides, and to methods of identifying B-raf mutations. The present application also relates to methods of diagnosing cancer; and methods and kits for predicting the usefulness of anti-EGFr specific binding agents in the treatment of tumors.
Patent CA-2682275-A1 (CA)
Inventor: BOYCE-JACINO MICHAEL
IPC: C12Q1/68
Filed: 2008-03-28
Abstract: Methods of analyzing features such as the physical size of macromolecules or biomarkers along large genomic DNA molecules were disclosed as well as the devices for carrying out such high throughput analysis in a massively parallel fashion. Methods of fabricating such devices are also disclosed. The sample embodiment shown in the figure illustrates detection of a macromolecule flowing through a nanochannel device where passage of the macromolecule through the nanochannel is recorded by exciting features of interest to fluoresce with an excitation source, and then sensing the fluorescence with a photon detection device, the resulting fluorescent signal being correlated along the length of the macromolecule.
Patent CA-2687974-A1 (CA)
Inventor: BHALLA RAJIV
IPC: C07D487/08
Filed: 2008-06-18
Abstract: The invention provides a method for radiofluorination of biological vectors such as peptides comprising reaction of a compound of formula (II): or a salt thereof with a source of [18F]-fluoride, to give a compound of formula (I): or a salt thereof. The method may be effected under mild reaction conditions and offers a more chemoselective labelling approach Novel reagents for use in the radiofluoridation method, and uses of the resultant 18F-labelled vectors are also provided
Patent CA-2688720-A1 (CA)
Inventor: NOREEN REBECCA
IPC: G06Q50/00
Filed: 2008-05-16
Abstract: The present invention provides systems and methods of analyzing healthcare data. In one embodiment, a Medical National Operations Center application (MNOC) displays clear, concise and actionable information, with visual indicators, to help Line of Service (LOS) teams to manage their operations by providing a dashboard of information. For example, the application may present selected summaries of data, baseline targets, customized metrics and interactive alerts that will be used to monitor, analyze and measure LOS performance. In one embodiment, the systems and methods of the present invention may be implemented in a health insurance provider system. As such, the present invention may provide access to additional, real-time data to evaluate initiatives allowing the LOS to react quickly to variances and expected results. Further, the present invention may provide tools to evaluate the effectiveness and performance of initiatives and programs, such as, for example, member steerage tools.
Patent CA-2689508-A1 (CA)
Title: Solid state illumination device
Inventor: PUGH MARK A
IPC: F21V9/40
Filed: 2008-06-06
Abstract: A solid state illumination device includes a semiconductor light emitter (106) mounted on a base (110) and surrounded by sidewalls (120), e.g., in a circular, elliptical, triangular, rectangular or other appropriate arrangement, to define a chamber (130). A top element (122), which may be reflective, may be coupled to the sidewalls to further define the chamber. The light produced by the semiconductor light emitter (106) is emitted through the sidewalls (120) of the chamber. The sidewalls and/or top element may include wavelength converting material, for example, as a plurality of dots on the surfaces. An adjustable wavelength converting element (452) may be used within the chamber, with the adjustable wavelength converting element (452) being configured to adjust the surface area that is exposed to the light emitted by the semiconductor light emitter in the chamber to alter an optical property of the chamber.
Patent CA-2690731-A1 (CA)
Inventor: YAN MIN
IPC: A63F13/00
Filed: 2008-03-20
Abstract: A method for controlling service access is provided. the method includes:  creating a service group comprising more than one client; searching, by a server, for a service component, wherein the number of users allowed to access the service component is larger than or equal to the number of the clients in the service group;  configuring the service component as being accessible to only the clients in the service group; and informing the clients in the service group that the service component is accessible; and accessing, by the clients in the service group, the service component. A  server and a system corresponding to the method are provided at the same time. By applying the method and system of the present invention, success ratio of the invitation is improved and the implementation procedure is simplified.
Patent CA-2690806-A1 (CA)
Title: Safety neural injection system and related methods
Inventor: RACZ NICHOLAS SANDOR
IPC: A61M5/178
Filed: 2008-06-13
Abstract: A safety neural injection system includes at least a partially hollow cannula having an inside diameter, an outside diameter, a first length, a side port located coaxially along the hollow cannula for fluid communication between the inside and the outside of the hollow cannula, and an open distal end. The safety neural injection system also includes a flexible stylet with a shaped tip. The flexible stylet is capable of being releasably locked in a position within the hollow cannula and extends at least the first length of the hollow cannula. The hollow cannula proximate to the distal end includes a rigid bend so as to facilitate placement of the distal end at the treatment site.
Patent CA-2692991-A1 (CA)
Inventor: SUNG JASON
IPC: C08G18/48
Filed: 2010-02-10
Abstract: Molded polyurethane foams are provided which are useful as seals and have an ultimate elongation of at least about 300%. The foams may be formed from a first composition including a polyol, a chain extender, optional surfactants, catalysts, and blowing agents, in combination with a second composition including a polyol and an isocyanate.
Patent CA-2693762-A1 (CA)
Inventor: ILLINGWORTH DAVID
IPC: A23L27/21
Filed: 2008-07-14
Abstract: The present invention relates to methods of making flavour concentrates, in particular lipid, condensed and solids flavour concentrates, together with the flavour concentrates produced thereby.  The flavour concentrates produced by the methods of the present invention have improved flavour and other characteristics and have wide application in the production of foods and beverages.